Disrupting fibrin sheath from a host blood vessel and visualization thereof
A percutaneous transluminal angioplasty (PTA) catheter may be configured to perform vein expansion and occlusion. A infusion port ( 132 ) located proximal to the occlusion feature ( 162 ) can be used to inject contract enhancement agent as well as other substances. The catheter can be used especially advantageously in vascular regions associated with hemodialysis access.
1. A method for disrupting a fibrin sheath from a host blood vessel and enhancing visualizing thereof, the method comprising:
removing a first dialysis catheter from the host blood vessel;
introducing a dilation balloon catheter into the host blood vessel wherein said dilation balloon catheter comprises a dilatation balloon, an infusion lumen, and a lateral infusion opening in said infusion lumen that is positioned proximal to said dilatation balloon;
positioning said dilatation balloon adjacent to a target location associated with boundaries of the fibrin sheath;
inflating said dilatation balloon so as to disrupt the fibrin sheath and occlude said host blood vessel;
injecting contrast enhancing material through said lateral infusion opening and into the fibrin sheath while said dilatation balloon is inflated and is occluding the host blood vessel for enabling visualization of remaining portions of said fibrin sheath;
verifying fibrin sheath disruption using imagery; and
replacing said dilation balloon catheter with a second dialysis catheter.
2. The method of claim 1 , wherein the host blood vessel is a superior vena cava.
3. The method of claim 1 , wherein said removing includes removing said first dialysis catheter over a guidewire.
4. The method of claim 1 , wherein said dilation balloon catheter comprises an inflation lumen for passing therethrough a balloon inflation fluid.
5. The method of claim 1 , wherein said lateral infusion opening is located proximally adjacent to said dilation balloon.
6. The method of claim 1 , further comprising: dispersing thrombolytic agents via said dilation balloon catheter.
7. The method of claim 1 , further comprising:
deflating said dilatation balloon;
repositioning said dilation balloon adjacent a different portion of the fibrin sheath; and
repeating at least one of said inflating, said injecting, and said verifying.
8. The method of claim 1 , comprising:
flushing said contrast enhancing material to disperse beyond the fibrin sheath; and
visualizing vasculature portions other than the host target vessel, including internal jugular vein.
9. The method of claim 1 , wherein said infusion lumen comprises a proximal opening and a distal opening that is distal to said dilatation balloon, and wherein said method further comprises:
inserting a guidewire into the host blood vessel; and
wherein said introducing is performed when said guidewire extends in said infusion lumen from said distal opening to said proximal opening.
10. The method of claim 9 , wherein said guidewire blocks a portion of said infusion lumen sized and shaped as external boundaries of said guidewire, such that said injecting causes said contrast enhancing material to exit mainly or only through said lateral infusion opening.
11. The method of claim 1 , wherein a valving mechanism is provided in said infusion lumen distal to said lateral infusion opening, wherein said injecting follows operating the valving mechanism such that said injecting causes said contrast enhancing material to exit mainly or only through said lateral infusion opening.